Thursday, March 7, 2019; 8:45 AM – 10:15 AM
Section outline
-
Lecture: Ethics in Clinical Trials and Interim Monitoring
Ethical issues in clinical trials, including choice of interventions in control and intervention groups, randomization, selection of subjects, and interim analysesWhy alter/stop a clinical trial early; who should decide to stop the trial; what parameters should be monitored and how often; what statistical methods should be used; statistical approaches
Faculty: Alison Huang
Location: Mission Hall 1400-
Lo B. Ethical issues in clinical trials, pages 1-7. File
-
Dixon D, Freedman R et al.. Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees. Clinical Trials 2006. Nov 3: 314-19. File
-
Bryant J and Wolmark N. Letrozole after tamoxifen for breast cancer--what is the price of success? N Engl J Med. 2003 Nov 6;349(19):1855-7. File
-
DeMets DL, Pocock SJ, Julian DG. The agonizing negative trend in monitoring of clinical trials. Lancet 1999:354:1983-88. File